Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Colorectal Neoplasms 2Recurrence 1Polycystic Ovary Syndrome 1Obesity 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lung Neoplasms 1Intraocular Lymphoma 1Inflammation 1Hodgkin Disease 1Frailty 1Corneal Endothelial Cell Loss 1Cataract 1Breast Neoplasms 1Anemia 1

Interventions

Geriatric Assessment 3microcrystalline cellulose 1epigallocatechin gallate 1diacetamate 1Therapeutics 1Temozolomide 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1Psychosocial Intervention 1Observation 1Methods 1Enhanced Recovery After Surgery 1Data Collection 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Frailty × Ascorbic Acid × Clear all
NCT06068543 2026-03-06

ReFOCUS2

University of Rochester

Phase 2 Recruiting
118 enrolled

Frailty, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡